Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6534
    +0.0034 (+0.52%)
     
  • OIL

    82.97
    +0.16 (+0.19%)
     
  • GOLD

    2,342.10
    +3.70 (+0.16%)
     
  • Bitcoin AUD

    97,685.77
    -4,161.28 (-4.09%)
     
  • CMC Crypto 200

    1,353.09
    -29.48 (-2.13%)
     
  • AUD/EUR

    0.6088
    +0.0018 (+0.29%)
     
  • AUD/NZD

    1.0950
    +0.0008 (+0.07%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,091.13
    +50.75 (+0.63%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,950.21
    -138.49 (-0.77%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Better Buy: McCormick vs. Procter & Gamble

Better Buy: McCormick vs. Procter & Gamble

Wall Street has warmed up to consumer staples stocks in recent months as the prospects rise for a recession in 2023. McCormick (NYSE: MKC) and Procter & Gamble (NYSE: PG) are both ideal stocks if you're looking for exposure to these positive investing traits. Both companies are seeing demand pressure as they raise prices in the face of slowing consumer spending.